Feature

Cell and Gene Therapy Catapult Establishes Technology Advisory Board 

  • By

  • February 19, 2026

  • 2 min

Share

The Cell and Gene Therapy Catapult in the UK has formed a Technology Advisory Board to facilitate the adoption of advanced therapies. Chaired by Dr. Phil Vanek, the board comprises experts in data, manufacturing, and regulatory processes. They aim to identify barriers and opportunities for adopting new technologies in patient treatments. Matthew Durdy, the Chief Executive, emphasized their mission to meet industry innovation needs and ensure advanced therapies benefit a wider audience. This initiative represents a crucial step in the evolution of the therapy landscape.

Original Source(s)

Related Content